Srs Capital Advisors, Inc. Bristol Myers Squibb CO Transaction History
Srs Capital Advisors, Inc.
- $901 Million
- Q1 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 981 shares of BMY stock, worth $40,083. This represents 0.01% of its overall portfolio holdings.
Number of Shares
981
Previous 862
13.81%
Holding current value
$40,083
Previous $44,000
20.45%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,557Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.6 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.64 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.74 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.63 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.87 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $86.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...